Check Out 3 Real Estate Stocks With Over 6% Dividend Yields From Wall Street's Most Accurate Analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.

Global Medical REIT Inc. GMRE

Dividend Yield: 8.48%
B. Riley Securities analyst Bryan Maher maintained a Buy rating and cut the price target from $12 to $11 on May 8, 2023. This analyst has an accuracy rate of 66%.
BMO Capital analyst John Kim downgraded the stock from Outperform to Market Perform and cut the price target from $13 to $9 on Oct. 6, 2022. This analyst has an accuracy rate of 67%.
Recent News: Global Medical REIT posted downbeat first-quarter sales.

Broadstone Net Lease, Inc. BNL

Dividend Yield: 6.87%
Morgan Stanley analyst Ronald Kamdem maintained an Equal-Weight rating and cut the price target from $20 to $19 on Dec. 16, 2022. This analyst has an accuracy rate of 61%.
BTIG analyst Michael Gorman maintained a Buy rating and raised the price target from $25 to $22 on Oct. 6, 2022. This analyst has an accuracy rate of 64%.
Recent News: Broadstone Net Lease posted better-than-expected first-quarter sales.

Physicians Realty Trust DOC

Dividend Yield: 6.24%
Credit Suisse analyst Omotayo Okusanya reiterated a Neutral rating with a price target of $15 on March 29, 2023. This analyst has an accuracy rate of 61%.
Keybanc analyst Todd Thomas upgraded the stock from Sector Weight to Overweight with a price target of $17 on Dec. 14, 2022. This analyst has an accuracy rate of 63%.
Recent News: Physicians Realty Trust reported first-quarter revenue increase of 3.0% Y/Y to $134.3 million, exceeding the consensus of $132.2 million.